A new study led by scientists at the University of Pennsylvania School of Veterinary Medicine has painted a clearer picture of the delicate arms race between the human immune system and a pathogen that seeks to infect and ...
May 5, 2014
0
0
Vaccines are an indispensable tool for reducing and even eradicating many infectious diseases. Ideally, countries are encouraged to take full ownership of their vaccination programs. However, some low- and middle-income countries ...
Jan 10, 2023
0
10
Researchers in the group of Prof. Dr. Peter Vandenabeele (VIB/UGent) show that killed tumour cells can serve as a potent vaccine that stimulates the immune system to prevent the outgrowth of cancer cells. This finding opens ...
Mar 31, 2016
0
3
A team of researchers led by Michael H. Antoni, director of the Center for Psycho-Oncology Research at the University of Miami (UM) has shown that a stress management program tailored to women with breast cancer can alter ...
Mar 21, 2012
0
0
(Medical Xpress)—Depleted numbers of a specific type of white blood cell in the immune systems of people infected with HIV/AIDS appear to be associated with increased levels of unchecked and often damaging inflammation ...
May 29, 2013
0
0
Scientists in Melbourne, Australia, have revealed the structure of a protein that is essential for triggering a form of programmed cell death, making possible the development of new drugs to treat chronic inflammatory diseases ...
Sep 5, 2013
0
0
New data being presented at IDWeek 2012 shows the fatal risk that influenza poses even for children without underlying health conditions and the effectiveness of school-based vaccination programs in protecting student populations. ...
Oct 19, 2012
0
0
A research team led by Children's National Medical Center has identified a trigger that causes latent Kaposi's sarcoma-associated herpesvirus (KSHV) to rapidly replicate itself. KSHV causes Kaposi's sarcoma, primary effusion ...
Apr 17, 2012
0
0
Natural killer cells are part of the innate immune system. Their role is to detect virus-infected cells and destroy them. When an infection is detected, a small subset of the most effective killer cells is identified and ...
Jun 3, 2019
0
0
Research funded by the Dengue Vaccine Initiative (DVI) involving an economic analysis of producing a tetravalent dengue vaccine shows that the cost could be as low as $0.20 per dose with an annual production level of 60 million ...
Jun 28, 2012
0
0
